Belinostat
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 353 publications
Hypophosphatemia as a Potential Class Effect of Histone Deacetylase Inhibitors: Evidence from Disproportionality Analysis and Mendelian Randomization Analysis of Drug Targets.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2026
Variant-dependent pharmacological rescue of phenylalanine hydroxylase supports a precision therapeutic strategy for phenylketonuria.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 12, 2026
Screening and evaluation of potential histone deacetylase inhibitors against Babesia infections.
Journal: International journal for parasitology. Drugs and drug resistance
Published: January 07, 2026
Tracing the Analytical Footprint of Belinostat: Exploring Pharmacology and Synthetic Framework.
Journal: Biomedical chromatography : BMC
Published: November 21, 2025
Characterization of a Novel Family of Contilisant + Belinostat Multitarget Small Molecules in Glioblastoma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 04, 2025
Retraction Note: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer.
Journal: Journal of cancer research and clinical oncology
Published: October 21, 2025
Proteome-wide multi-trait association analyses prioritize candidate proteins and therapeutic targets for psychiatric disorders.
Journal: Journal of affective disorders
Published: August 22, 2025
Cross-resistance of Belinostat and Romidepsin in Non-T Follicular Helper Peripheral T-cell Lymphoma Models Suggests Subtype-Specific Implications for Belinostat-CHOP.
Journal: Molecular cancer therapeutics
Published: August 11, 2025
Comprehensive Analysis to Reveal Nitrogen Metabolism-Associated Genes as a Prognostic Index in Head and Neck Squamous Cell Cancer.
Journal: Current medicinal chemistry
Published: July 18, 2025
Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis.
Journal: Brain research
Published: June 25, 2025
Protein domain movement involved in binding of belinostat and HPOB as inhibitors of histone deacetylase 6 (HDAC6): a hybrid automated-interactive docking study.
Journal: Journal of computer-aided molecular design
Published: May 28, 2025
Last Updated: 06/30/2026